Syringaresinol protects against diabetic nephropathy by inhibiting pyroptosis via NRF2-mediated antioxidant pathway-Reference-Cited by-同舟云学术

Syringaresinol protects against diabetic nephropathy by inhibiting pyroptosis via NRF2-mediated antioxidant pathway

Published:2023-01-14 Issue:3 Volume:39 Page:621-639
ISSN:0742-2091
Container-title:Cell Biology and Toxicology
language:en
Short-container-title:Cell Biol Toxicol

Author:

Li Guangru,Liu Chang,Yang Lei,Feng Lifeng,Zhang Shengzheng,An Jiale,Li Jing,Gao Yang,Pan Zhongjie,Xu Yang,Liu Jie,Wang Yachen,Yan Jie,Cui Jianlin,Qi Zhi,Yang Liang

Funder

National Natural Science Foundation of China

Natural Science Foundation of Tianjin City

Tianjin Key Medical Discipline (Specialty) Construction Project; Key Laboratory of Emergency and Trauma (Hainan Medical University), Ministry of Education

Fundamental Research Funds for the Central Universities

Publisher

Springer Science and Business Media LLC

Subject

Health, Toxicology and Mutagenesis,Cell Biology,Toxicology

Link

https://link.springer.com/content/pdf/10.1007/s10565-023-09790-0.pdf

Reference48 articles.

1. Adelusi TI, Du L, Hao M, Zhou X, Xuan Q, Apu C, et al. "Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy. Biomed Pharmacother. 2020;123:109732. https://doi.org/10.1016/j.biopha.2019.109732.

2. Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032–45. https://doi.org/10.2215/cjn.11491116.

3. An XY, Zhang Y, Cao J, Chen H, Qin and Yang L (2020). "Punicalagin protects diabetic nephropathy by inhibiting pyroptosis based on TXNIP/NLRP3 pathway." Nutrients 12(5). https://doi.org/10.3390/nu12051516

4. Baird L, Yamamoto M (2020). "The molecular mechanisms regulating the KEAP1-NRF2 pathway." Mol Cell Biol 40(13). https://doi.org/10.1128/mcb.00099-20